Johnson & Johnson Western Hemisphere, excluding U.S. — Percent Change increased by 120.4% to 10.8% in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 569.6%, from -2.3% to 10.8%. This is a positive signal — higher values indicate stronger performance for this metric.
A positive percentage indicates organic growth or market share gains in the region, while a negative percentage signals a contraction or loss of market share.
This metric measures the period-over-period percentage growth or decline in net sales for the Western Hemisphere, exclud...
Comparable to regional organic growth rates or constant currency growth metrics reported by global pharmaceutical and medical device competitors.
jnj_segment_western_hemisphere_excluding_u_s_percent_change| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 20.6% | 15.7% | 4.1% | 12.4% | 4.1% | 7.1% | 11.5% | 10.5% | 11% | 6.7% | 0.3% | -2.3% | -0.5% | 4.9% | 10.8% |
| QoQ Change | — | -23.8% | -73.9% | +202.4% | -66.9% | +73.2% | +62.0% | -8.7% | +4.8% | -39.1% | -95.5% | -866.7% | +78.3% | >999% | +120.4% |
| YoY Change | — | — | — | -39.8% | -73.9% | +73.2% | -7.3% | +156.1% | +54.9% | -41.7% | -97.1% | -120.9% | -107.5% | >999% | +569.6% |